FDA Approves IGF-1

[huge-inc]

IGF-1 drug approved by FDA




Insulin like-Growth Factor (IGF-1) is required for both cartilage and bone growth in children’s and the secretion of IGF is mediated by the pituitary gland. Deficiency of IGF-1 results in impaired growth and is associated with metabolic abnormalities including insulin resistance, increased adiposity and delayed wound healing. IGF-1 drugs helps in production of IGF-1 in children’s with deficiency in production of IGF-1.

The pharmaceutical company Tercica drug, Increlex against IGF-1 deficiency has been approved by the U.S. FDA to produce recombinant human IGF-1 as a long term treatment for children with severe primary IGF-1 deficiency. The results of the new recombinant drug has to be monitored as earlier IGF-1 drugs produced by pharmaceuticals like Genetech for treatment of diabetes and Cephalon pharmacies IGF-1 drug against Amyotrophic lateral sclerosis had been withdrawn due to its side effects in patients.



Medindia on Paediatrics: Medindia provides a very interesting Paediatric section for doctors and their patients Some of the highlights of the pages include the following.

For More Information

http://www.medindia.net/patients/
paediatrics/index.asp

http://www.medindia.net/patients/
childhealth.asp

 

[huge-inc]

Brain site

Found this info on my brain anuersym site...read down near the bottom about side effects with Gentech

 

[JETHRO TULL]

Good post, Huge!

Thanks.

 

[bigbaldbulldog]

Does thisw mean it will be easier or harder to get and will the price go up?

 

[Pinnacle]

Does thisw mean it will be easier or harder to get and will the price go up?

This is in reference to rIGF,which is quite different than LR3 IGF-1.


~Pinnacle~